Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02267863
Title A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aptose Biosciences Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
UC San Diego Moores Cancer Center La Jolla California 92093-0698 United States Details
University of California, Irvine Orange California 92868 United States Details
Emory University; Winship Cancer Institute Atlanta Georgia 30322 United States Details
Ochsner Cancer Institute New Orleans Louisiana 70121 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
St. Vincent Frontier Cancer Center Billings Montana 59102 United States Details
University of Rochester; Wilmot Cancer Institute Clinical Trials Office Rochester New York 14643 United States Details
University Hospital Cleveland Ohio 44106 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Prisma Health, Institute for Translational Oncology Research Greenville South Carolina 29605 United States Details
Baylor Research Institute Dallas Texas 75246 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field